About Coronin-2A
Coronin-2A (CORO2A) is a protein
from Homo sapiens identified by UniProt accession
Q92828, 525 residues long.
MolForge cross-references it against 0 known binders and
43 disease associations.
Target properties
| Protein name | Coronin-2A |
| UniProt accession | Q92828 |
| Gene | CORO2A |
| Organism | Homo sapiens |
| Length | 525 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (43)
Diseases linked to this target (Open Targets).
- myoepithelial tumor · score 0.11
- bone density · score 0.10
- urate measurement · score 0.10
- oral squamous cell carcinoma · score 0.07
- multiple sclerosis · score 0.05
- smoking status measurement · score 0.04
- adolescent idiopathic scoliosis · score 0.04
- body height · score 0.03
- childhood trauma measurement · score 0.03
- alcohol consumption measurement · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92828-F1 | alphafold | PREDICTED | 85.39 | — |
Amino-acid sequence (525 residues)
MSWHPQYRSS KFRHVFGKPA SKENCYDSVP ITRSVHDNHF CAVNPHFIAV VTECAGGGAF LVIPLHQTGK LDPHYPKVCG HRGNVLDVKW NPFDDFEIAS CSEDATIKIW SIPKQLLTRN LTAYRKELVG HARRVGLVEW HPTAANILFS AGYDYKVMIW NLDTKESVIT SPMSTISCHQ DVILSMSFNT NGSLLATTCK DRKIRVIDPR AGTVLQEASY KGHRASKVLF LGNLKKLMST GTSRWNNRQV ALWDQDNLSV PLMEEDLDGS SGVLFPFYDA DTSMLYVVGK GDGNIRYYEV SADKPHLSYL TEYRSYNPQK GIGVMPKRGL DVSSCEIFRF YKLITTKSLI EPISMIVPRR SESYQEDIYP PTAGAQPSLT AQEWLSGMNR DPILVSLRPG SELLRPHPLP AERPIFNSMA PASPRLLNQT EKLAAEDGWR SSSLLEEKMP RWAAEHRLEE KKTWLTNGFD VFECPPPKTE NELLQMFYRQ QEEIRRLREL LTQREVQAKQ LELEIKNLRM GSEQL
Explore Coronin-2A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets